121 related articles for article (PubMed ID: 15649726)
1. A comparison of six statins on the development of intimal hyperplasia in a human vein culture model.
Corpataux JM; Naik J; Porter KE; London NJ
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):177-81. PubMed ID: 15649726
[TBL] [Abstract][Full Text] [Related]
2. Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9.
Porter KE; Turner NA
Biochem Soc Trans; 2002 Apr; 30(2):120-6. PubMed ID: 12023838
[TBL] [Abstract][Full Text] [Related]
3. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
4. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
5. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
6. Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia.
Peterson M; Porter KE; Loftus IM; Thompson MM; London NJ
Eur J Vasc Endovasc Surg; 2000 May; 19(5):461-7. PubMed ID: 10828225
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.
Porter KE; Naik J; Turner NA; Dickinson T; Thompson MM; London NJ
J Vasc Surg; 2002 Jul; 36(1):150-7. PubMed ID: 12096273
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
9. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
10. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
Schachner T; Steger C; Heiss S; Bonaros N; Sterlacci W; Laufer G; Bonatti J
Eur J Cardiothorac Surg; 2007 Dec; 32(6):906-11. PubMed ID: 17923411
[TBL] [Abstract][Full Text] [Related]
12. Marimastat inhibits neointimal thickening in a model of human vein graft stenosis.
Porter KE; Loftus IM; Peterson M; Bell PR; London NJ; Thompson MM
Br J Surg; 1998 Oct; 85(10):1373-7. PubMed ID: 9782017
[TBL] [Abstract][Full Text] [Related]
13. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture.
Patterson MA; Leville CD; Hower CD; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
J Surg Res; 2001 Jan; 95(1):67-72. PubMed ID: 11120638
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide treatment reduces neo-intimal formation and modulates osteopontin expression in an ex-vivo human model of intimal hyperplasia.
Colotti C; Vittorini S; Ottaviano V; Maltinti M; Angeli V; Del Ry S; Giannessi D
Cytokine; 2009 May; 46(2):228-35. PubMed ID: 19285424
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous vein.
Rey J; Probst H; Mazzolai L; Bosman FT; Pusztaszeri M; Stergiopulos N; Ris HB; Hayoz D; Saucy F; Corpataux JM
J Surg Res; 2004 Sep; 121(1):42-9. PubMed ID: 15313374
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
17. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair.
Meng X; Mavromatis K; Galis ZS
Exp Mol Pathol; 1999 Aug; 66(3):227-37. PubMed ID: 10486241
[TBL] [Abstract][Full Text] [Related]
18. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
19. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells.
Corpataux JM; Naik J; Porter KE; London NJ
J Surg Res; 2005 Nov; 129(1):52-6. PubMed ID: 16087194
[TBL] [Abstract][Full Text] [Related]
20. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
